GE HealthCare (GEHC) announced the FDA has approved a pediatric indication for its Optison ultrasound enhancing agent. This approval will help improve the clarity of echocardiograms for diagnosing heart conditions in pediatric patients, enhancing the assessment of ventricular function. Optison, the only PEG-free UEA available in the U.S., was first approved for adult use in 1997.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare, Raydiant Oximetry announce joint development initiative
- GE HealthCare unveils gradient 1.5T MRI system
- GE Hlthcare Tech Inc put volume heavy and directionally bearish
- Microsoft downgraded, Reddit upgraded: Wall Street’s top analyst calls
- UBS upgrades GE HealthCare to Neutral with ‘worst case’ priced in